Construction of 740 Dr Penfield Avenue was made possible through one shared vision - to improve health care research for all Canadians. Please read on for an alphabetical list of partners who helped transform that dream into a reality.
Construction of 740 Dr Penfield Avenue was made possible through one shared vision - to improve health care research for all Canadians. Please read on for an alphabetical list of partners who helped transform that dream into a reality:
Applied Biosystems, a business unit of Applera Corporation, develops and markets instrument-based systems, reagents, software, and contract related services to the life science industry and research community. These technologies enable biological discoveries in life science research, pharmaceutical research and development, diagnostics, and agriculture. Its broad portfolio of technologies, which includes DNA sequencing, PCR, organic synthesis, chemiluminescence, mass spectrometry, and information management systems, enable genomics, proteomics, high throughput screening and other molecular analyses. Read more.
Canada Economic Development's mandate is to promote the economic development of the regions of Quebec. To that end, the Agency focuses on two main areas of activity-Enterprise development and Improving the environment for economic development of the regions-thus contributing directly to the attainment of the Government of Canada's economic priorities, particularly with respect to innovation, competitiveness, local development and sustainable development. Read more
. Canada Foundation for Innovation (CFI) is an independent corporation established by the Government of Canada in 1997. The Foundation's goal is to strengthen the capability of Canadian universities, colleges, research hospitals, and other not-for-profit institutions to carry out world-class research and technology development. By investing in research infrastructure projects, the CFI supports research excellence and helps strengthen research training at institutions across Canada. Read more
Caprion Pharmaceuticals Inc. is a privately held drug discovery company applying proteomics to discover and develop innovative products for the diagnosis and treatment of disease. CellCarta(tm), Caprion's proprietary subcellular proteomics platform, combines the power of biology and informatics to map the proteomes of organelles isolated from healthy and diseased tissue and uncover protein variations associated with disease. Using these protein maps, Caprion identifies clinically relevant drug targets and functional insights for drug development in areas such as cancer, metabolic disorders and infectious diseases. The Company is also developing products for Mad Cow Disease and variant Creutzfeldt-Jacob Disease diagnostics with their partners IDEXX Laboratories and Ortho-Clinical Diagnostics. Read more.
Donner Canadian Foundation (DCF) was established in 1950 by William H. Donner. Since1967, the DCF has contributed over $100 million to more than 1,000 projects across Canada. The Foundation's grant-making continues under the guidance of a Board of Governors composed of the Donner family and eminent Canadians from a variety of fields. The Donner Canadian Foundation seeks to encourage individual responsibility and private initiative to help Canadians solve their social and economic problems. Read more.
GeneChem Therapeutics Venture Fund L.P was launched in 2000, based on the changing landscape of the genomics industry and the initial success of 1997's GeneChem Therapeutics Venture Fund L.P. At that time, the human genome was on the verge of being entirely sequenced and it was becoming apparent that while early estimates accounted for approximately 150,000 genes, recent estimates accounted for only a fraction of that. Indeed, it has become apparent that the complexity of the human genome and more importantly of human disease, lies in how human genes are expressed (when and where) and how they interact together rather than in the intrinsic number of genes in the human genome or in the number involved in any particular disease. With committed capital of $136.5 million, the Therapeutics Fund's objectives are to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes. Diseases for which there are unmet medical needs, large market opportunities and where genomics has yet to make its mark. Status of the Fund: Actively investing and seeking opportunities. Read more.
Genome Canada is the primary funding and information resource relating to genomics and proteomics in Canada. Dedicated to developing and implementing a national strategy in genomics and proteomics research for the benefit of all Canadians, it has so far received $375 million from the Government of Canada. Genome Canada has established five Genome Centres across the country (Atlantic, Québec, Ontario, Prairies and British Columbia) and has as a main objective to ensure that Canada becomes a world leader in genomics and proteomics research. Read more.
Génome Québec is a not-for-profit investment organization created to implement and apply a comprehensive strategy for the genomics and proteomics research sector in Quebec. Working with universities and multiple private-sector partners, Génome Québec's mission is to establish in Quebec as one of the world's largest genomics research centres. Génome Québec manages 17 large-scaled research projects, valued at over $180 million, in key selected areas: human health, ethics, environment and foretry (??). Génome Québec also launched a high technology platform 21 months ago called the McGill University and Génome Québec Innovation Centre (formerly known as the Montreal Genome Centre). The Centre's two major financial partners are Genome Canada and the Ministère du Développement économique et régional du gouvernement du Québec. Read more.
McGill University has earned an international reputation for scholarly achievement and scientific discovery. Founded in 1821, McGill is one of two Canadian members of the American Association of Universities, which it joined in 1925. McGill's 22 faculties and professional schools offer more than 300 programs, from the undergraduate to the doctoral level. The University's professors have earned graduate degrees and completed their training in leading academics centres around the world. McGill attracts students from over 150 countries, creating one of the most dynamic and diverse student bodies in North America. The University has approximately 17,611 full time undergraduate students and 6,362 graduate students.
The Ministère de l'Éducation du Québec is the government authority responsible for seeing that Quebec citizens receive the educational services they need in order to develop as individuals and become active, contributing members of society. The Ministère assumes the role and responsibilities entrusted to it in the Act respecting the ministère de l'Éducation by exercising the following five horizontal functions: orientation and planning of the educations services offered in Quebec's territory, in keeping with the needs of Quebec and of its population; allocation of resources to educational institutions and management of certain programs; evaluation of the education system and the level to which it has attainted it stated objectives; dissemination to the public of information o the performance and state of the education system; expertise and advice to the legislator and to political leaders. The Ministère performs this mission on the basis of a division of responsibilities between the government and the authorities and individuals in the education system. Except where student financial assistance is concerned, in which case the Ministère deals directly with students, the Ministère interacts mainly with the various educational institutions in charge of offering programs of student and other educational services. Read more.
Ministère du Développement économique et regional: The Ministry's mission is to promote research, science, technology and innovation by fostering synergies between different players that work in the aforementioned fields. The Ministry's mandate includes the creation of a general policy for research, science, technology and innovation, with the collaboration of university, CEGEP, industry and governmental partners. Policies developed by the Ministry must have measurable societal, cultural and economic benefits that balance the particularities of Quebec's diverse regions. Read more.
Pierrette Wong and Family: The relationship between the Faculty of Dentistry and the Wong family is multigenerational. Pierrette Wong, with daughters Tanya and Jennifer, are major donors of the new Jamson T.N. Wong Laboratories in Bone and Periodontal Research -- named in honor of their late husband and father. Pierrette Wong has been involved with the Faculty of Dentistry since 1999, when she co-chaired a fundraising event and made a significant personal gift in support of the Faculty's Outreach Program. She has remained committed through major support directed at establishing the Jamson T.N. Wong Laboratories in Bone and Periodontal Research, which will provide a unique environment for researchers and students to work and study.
Research Institute of the McGill University Health Centre (MUHC) is Canada's largest concentration of biomedical and health-care researchers. The Institute has over 500 researchers, nearly 650 graduate and post-doctoral students and 306 laboratories devoted to research. The mission of the Institute is to facilitate investigator-initiated and discovery-driven research that creates new knowledge. This research is inextricably linked to clinical programs, which provide a bench-to-bedside-to-community continuum. The MUHC Research Institute is renowned as a world-class research institution that operates at the forefront of new knowledge, innovation, trends and technologies. Read more.
Valorisation-Recherche Québec is a non-profit investment corporation created in March 1999 by the Government of Quebec. The VRQ's mandate is to promote the commercialization of research conducted by educational and research institutions to create jobs and better society. Armed with a venture capital fund of $100 million, the VRQ aims to heighten the competitiveness of Quebec researchers on an international scale. Read more.